Lefaucheur et al. showed in a prospective cohort study of 1845 patients that participants with anti-angiotensin II type 1-receptor antibodies (AT1R-Abs)-associated rejection had a higher prevalence of hypertension and more vascular rejection with arterial inflammation [54]. This evidence concerns the gene AGTR1 and Hypertension.